Welcome to our new website. We have rebranded from Atnahs to Pharmanovia — read more

1st December 2018

Atnahs Opens New Branch in the United Arab Emirates (UAE)

Dubai, UAE. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new...

More information
28th February 2018

Atnahs Acquires Remaining Stake in Pharmanovia A/S in Denmark

Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of the remaining share capital...

More information
1st November 2017

Atnahs Launches Traxidot® (Tranexamic Acid) in the Netherlands

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the launch of Traxidot® (Tranexamic...

More information
1st October 2017

Atnahs Opens New Branch in India

Baroda, India. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new...

More information
7th July 2017

Atnahs Launches Clobazam in UK, Iloprost in Portugal and Dropizol® in Denmark

Atnahs Pharma UK Limited (“Atnahs”), and its partners Pharmanovia A/S (“Pharmanovia”) and Pharmamentum ApS (“Pharmamentum”), are...

More information
3rd July 2017

Atnahs Acquires Rights for Bonviva® and Bondronat®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of worldwide rights...

More information
3rd January 2017

Atnahs Acquires Kytril®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Kytril® from...

More information
3rd June 2016

Statement Regarding Recent Media Coverage

Basildon, UK, 3 June 2016 – Atnahs Pharma is providing the following statement in relation to...

More information
11th May 2016

Atnahs Acquires Naproxen Suspension in the US

Basildon, UK, May 11 2016 – Atnahs Pharma US Limited (“Atnahs”) is pleased to announce that...

More information